Advertisement
Screener

Scilex Holding Company (SCLX) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

Scilex Holding Company Basic Shares Outstanding (Weighted Average)

Scilex Holding Company (SCLX) reported Basic Shares Outstanding (Weighted Average) of 6.89 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14

  • Scilex Holding Company weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 6.89M shares, a 40.56% decline year-over-year.
  • Scilex Holding Company weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 6.89M shares, a 40.42% decline year-over-year.
  • Scilex Holding Company weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 9.37K shares, a 62.00% decline year-over-year.
  • Scilex Holding Company weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 11.60K shares, a 53.55% increase year-over-year.
  • Scilex Holding Company weighted average number of shares outstanding, basic for fiscal 2025 was 11.03K shares, a 9.67% increase from fiscal 2024.
  • Scilex Holding Company weighted average number of shares outstanding, basic for fiscal 2024 was 10.06K shares, a 99.99% decline from fiscal 2023.
  • Scilex Holding Company weighted average number of shares outstanding, basic for fiscal 2023 was 130.30M shares, a 2.93% decline from fiscal 2022.
  • Scilex Holding Company weighted average number of shares outstanding, basic for fiscal 2022 was 134.23M shares, a 1.03% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 6 month as first filedWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 10 monthWeighted Average Number of Shares Outstanding, Basic 12 monthWeighted Average Number of Shares Outstanding, Basic 12 month as first filed
2026-06-306.89M shares
10-Q · filed 2026-08-14
6.89M shares
10-Q · filed 2026-08-14
4.60M shares
derived: average of 3 quarters · filed 2026-08-14
3.45M shares
derived: average of 4 quarters · filed 2026-08-14
2026-03-316.89M shares
10-Q · filed 2026-05-20
3.45M shares
derived: average of 2 quarters · filed 2026-05-20
2.30M shares
derived: average of 3 quarters · filed 2026-05-20
4.63M shares
derived: average of 4 quarters · filed 2026-08-14
2025-12-319.37K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10
10.49K shares
derived: average of 2 quarters · filed 2026-04-10
3.87M shares
derived: average of 3 quarters · filed 2026-08-14
11.03K shares
10-K · filed 2026-04-10
2025-09-3011.60K shares
10-Q · filed 2025-11-14
5.80M shares
derived: average of 2 quarters · filed 2026-08-14
11.59K shares
10-Q · filed 2025-11-14
5.80M shares
derived: average of 4 quarters · filed 2026-08-14
2025-06-3011.60M shares
10-Q · filed 2026-08-14
11.60K shares
10-Q · filed 2025-08-13
11.58M shares
10-Q · filed 2026-08-14
11.58K shares
10-Q · filed 2025-08-13
7.73M shares
derived: average of 3 quarters · filed 2026-08-14
5.80M shares
derived: average of 4 quarters · filed 2026-08-14
2025-03-3111.56M shares
10-Q · filed 2026-05-20
11.56K shares
10-Q · filed 2025-05-14
5.79M shares
derived: average of 2 quarters · filed 2026-05-20
3.87M shares
derived: average of 3 quarters · filed 2026-05-20
2.90M shares
derived: average of 4 quarters · filed 2026-05-20
2024-12-3124.66K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10
16.11K shares
derived: average of 2 quarters · filed 2026-04-10
12.37K shares
derived: average of 3 quarters · filed 2026-04-10
10.06K shares
10-K · filed 2026-04-10
131.14M shares
10-K · filed 2025-03-31
2024-09-307.56K shares
10-Q · filed 2025-11-14
126.96K shares
10-Q · filed 2025-01-17
6.23K shares
derived: average of 2 quarters · filed 2025-11-14
5.19K shares
10-Q · filed 2025-11-14
118.57K shares
10-Q · filed 2025-01-17
130.20M shares
derived: average of 4 quarters · filed 2025-11-14
2024-06-304.90K shares
10-Q · filed 2025-08-13
120.19K shares
10-Q · filed 2024-08-13
4.00K shares
10-Q · filed 2025-08-13
111.45K shares
10-Q · filed 2024-08-13
173.59M shares
derived: average of 3 quarters · filed 2025-08-13
130.23M shares
derived: average of 4 quarters · filed 2025-08-13
2024-03-312.93K shares
10-Q · filed 2025-05-14
102.41K shares
10-Q · filed 2024-05-13
260.39M shares
derived: average of 2 quarters · filed 2025-05-14
173.64M shares
derived: average of 3 quarters · filed 2025-05-14
130.26M shares
derived: average of 4 quarters · filed 2025-05-14
2023-12-31520.77M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
260.45M shares
derived: average of 2 quarters · filed 2025-03-31
173.68M shares
derived: average of 3 quarters · filed 2025-03-31
130.30M shares
10-K · filed 2025-03-31
2023-09-30139.81K shares
10-Q · filed 2025-01-17
139.81M shares
10-Q · filed 2023-11-14
141.22K shares
derived: average of 2 quarters · filed 2025-01-17
141.36K shares
10-Q · filed 2025-01-17
141.36M shares
10-Q · filed 2023-11-14
34.55M shares
derived: average of 4 quarters · filed 2025-01-17
2023-06-30142.63K shares
10-Q · filed 2024-08-13
142.63M shares
10-Q · filed 2023-08-11
142.15K shares
10-Q · filed 2024-08-13
142.15M shares
10-Q · filed 2023-08-11
46.01M shares
derived: average of 3 quarters · filed 2024-08-13
67.78M shares
derived: average of 4 quarters · filed 2024-08-13
2023-03-31141.66K shares
10-Q · filed 2024-05-13
141.66M shares
10-Q · filed 2023-05-12
68.95M shares
derived: average of 2 quarters · filed 2024-05-13
90.32M shares
derived: average of 3 quarters · filed 2024-05-13
101.00M shares
derived: average of 4 quarters · filed 2024-05-13
2022-12-31137.76M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
135.41M shares
derived: average of 2 quarters · filed 2024-03-12
134.63M shares
derived: average of 3 quarters · filed 2024-03-12
134.23M shares
10-K · filed 2024-03-12
134.23K shares
10-K · filed 2023-03-07
2022-09-30133.06M shares
10-Q · filed 2023-11-14
13.18M shares
10-Q · filed 2022-11-04
133.06M shares
derived: average of 2 quarters · filed 2023-11-14
133.05M shares
10-Q · filed 2023-11-14
15.86M shares
10-Q · filed 2022-11-04
220.14M shares
derived: average of 4 quarters · filed 2024-03-12
2022-06-30133.06M shares
10-Q · filed 2023-08-11
17.21M shares
10-Q · filed 2022-08-12
133.04M shares
10-Q · filed 2023-08-11
17.23M shares
10-Q · filed 2022-08-12
249.16M shares
derived: average of 3 quarters · filed 2024-03-12
191.19M shares
derived: average of 4 quarters · filed 2024-03-12
2022-03-31133.03M shares
10-Q · filed 2023-05-12
17.25M shares
10-Q · filed 2022-05-16
307.22M shares
derived: average of 2 quarters · filed 2024-03-12
210.56M shares
derived: average of 3 quarters · filed 2024-03-12
162.23M shares
derived: average of 4 quarters · filed 2024-03-12
2021-12-31481.40M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12
249.33M shares
derived: average of 2 quarters · filed 2024-03-12
171.97M shares
derived: average of 3 quarters · filed 2024-03-12
132.86M shares
10-K · filed 2024-03-12
16.82M shares
10-K · filed 2022-02-24
2021-09-3017.25M shares
10-Q · filed 2022-11-04
17.25M shares
derived: average of 2 quarters · filed 2022-11-04
16.68M shares
10-Q · filed 2022-11-04
2021-06-3017.25M shares
10-Q · filed 2022-08-12
16.39M shares
10-Q · filed 2022-08-12
2021-03-3115.51M shares
10-Q · filed 2022-05-16
2020-12-313.00M shares
10-K · filed 2022-02-24
132.89K shares
10-K · filed 2023-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Instil Bio, Inc. (TIL)United States$0.048B-1.73
Tevogen Inc. (TVGN)United States$0.049B
aTYR PHARMA INC (ATYR)United States$0.033B-0.98
Quince Therapeutics, Inc. (QNCX)United States$0.031B
CEL SCI CORP (CVM)United States$0.030B-0.81
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21